[HTML][HTML] CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization

S Horie, SJ Robbie, J Liu, WK Wu, RR Ali… - Scientific reports, 2013 - nature.com
S Horie, SJ Robbie, J Liu, WK Wu, RR Ali, JW Bainbridge, LB Nicholson, M Mochizuki…
Scientific reports, 2013nature.com
Macrophages are rapidly conditioned by cognate and soluble signals to acquire phenotypes
that deliver specific functions during inflammation, wound healing and angiogenesis.
Whether inhibitory CD200R signaling regulates pro-angiogenic macrophage phenotypes
with the potential to suppress ocular neovascularization is unknown. CD200R-deficient
bone marrow derived macrophages (BMMΦ) were used to demonstrate that macrophages
lacking this inhibitory receptor exhibit enhanced levels of Vegfa, Arg-1 and Il-1β when …
Abstract
Macrophages are rapidly conditioned by cognate and soluble signals to acquire phenotypes that deliver specific functions during inflammation, wound healing and angiogenesis. Whether inhibitory CD200R signaling regulates pro-angiogenic macrophage phenotypes with the potential to suppress ocular neovascularization is unknown. CD200R-deficient bone marrow derived macrophages (BMMΦ) were used to demonstrate that macrophages lacking this inhibitory receptor exhibit enhanced levels of Vegfa, Arg-1 and Il-1β when stimulated with PGE2 or RPE-conditioned (PGE2-enriched) media. Endothelial tube formation in HUVECs was increased when co-cultured with PGE2-conditioned CD200R−/− BMMΦ, and laser-induced choroidal neovascularization was enhanced in CD200R-deficient mice. In corroboration, signaling through CD200R results in the down-regulation of BMMΦ angiogenic and pro-inflammatory phenotypes. Translational potential of this pathway was investigated in the laser-induced model of choroidal neovascularization. Local delivery of a CD200R agonist mAb to target myeloid infiltrate alters macrophage phenotype and inhibits pro-angiogenic gene expression, which suppresses pathological angiogenesis and CNV development.
nature.com